Acyclovir 65219-0622-10
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 16, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA215404
Need to source Acyclovir? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Acyclovir Sodium | 50 mg/mL |
Drug Class
DNA Polymerase Inhibitors [MoA]Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
Selected Package
65219-0622-10Selected10 VIAL in 1 CARTON (65219-622-10) / 10 mL in 1 VIAL (65219-622-02)